{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T23:34:40Z","timestamp":1789947280631,"version":"4.0.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,12,6]],"date-time":"2016-12-06T00:00:00Z","timestamp":1480982400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Swiss National Science Foundation through Joint research project (SCOPES)","award":["IZ73Z0_152420\/1."],"award-info":[{"award-number":["IZ73Z0_152420\/1."]}]},{"DOI":"10.13039\/501100004564","name":"Ministry of education, science, and technological development of the Republic of Serbia","doi-asserted-by":"crossref","award":["175053"],"award-info":[{"award-number":["175053"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s00277-016-2890-9","type":"journal-article","created":{"date-parts":[[2016,12,6]],"date-time":"2016-12-06T10:50:35Z","timestamp":1481021435000},"page":"393-404","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Bone marrow microvessel density and plasma angiogenic factors in myeloproliferative neoplasms: clinicopathological and molecular correlations"],"prefix":"10.1007","volume":"96","author":[{"given":"Danijela","family":"Lekovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjana","family":"Gotic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radek","family":"Skoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojana","family":"Beleslin-Cokic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasa","family":"Milic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivera","family":"Mitrovic-Ajtic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronny","family":"Nienhold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dijana","family":"Sefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tijana","family":"Suboticki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijana","family":"Buac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragana","family":"Markovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milos","family":"Diklic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladan P.","family":"Cokic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,6]]},"reference":[{"key":"2890_CR1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.exphem.2015.06.007","volume":"43","author":"RC Skoda","year":"2015","unstructured":"Skoda RC, Duek A, Grisouard J (2015) Pathogenesis of myeloproliferative neoplasms. Exp Hematol 43:599\u2013608","journal-title":"Exp Hematol"},{"key":"2890_CR2","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","volume":"352","author":"R Kralovics","year":"2005","unstructured":"Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR et al (2005) A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 352:1779\u20131790","journal-title":"N Engl J Med"},{"key":"2890_CR3","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1182\/blood-2006-04-018879","volume":"108","author":"AD Pardanani","year":"2006","unstructured":"Pardanani AD, Levine RL, Lasho T, Pikman Y, Mesa RA, Wadleigh M et al (2006) MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients. Blood 108:3472\u20133476","journal-title":"Blood"},{"key":"2890_CR4","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","volume":"369","author":"T Klampfl","year":"2013","unstructured":"Klampfl T, Gisslinger H, Harutyunyan AS, Nivarthi H, Rumi E, Milosevic JD et al (2013) Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med 369:2379\u20132390","journal-title":"N Engl J Med"},{"issue":"3","key":"2890_CR5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.critrevonc.2007.01.006","volume":"62","author":"R Roskoski Jr","year":"2007","unstructured":"Roskoski R Jr (2007) Vascular endothelial growth factor (VEGF) signaling in tumor progression. Crit Rev Oncol Hematol 62(3):179\u2013213","journal-title":"Crit Rev Oncol Hematol"},{"key":"2890_CR6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm0195-27","volume":"1","author":"J Folkman","year":"1995","unstructured":"Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27\u201331","journal-title":"Nat Med"},{"key":"2890_CR7","first-page":"2210","volume":"8","author":"SV Rajkumar","year":"2002","unstructured":"Rajkumar SV, Mesa RA, Fonseca R, Schroeder G, Plevak MF, Dispenzieri A et al (2002) Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis. Clin Cancer Res 8:2210\u20132216","journal-title":"Clin Cancer Res"},{"key":"2890_CR8","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1182\/blood.V95.8.2637","volume":"95","author":"T Padro","year":"2000","unstructured":"Padro T, Ruiz S, Bieker R, B\u00fcrger H, Steins M, Kienast J et al (2000) Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood 95:2637\u20132644","journal-title":"Blood"},{"issue":"9","key":"2890_CR9","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.2174\/156800911798073104","volume":"11","author":"A Aguayo","year":"2011","unstructured":"Aguayo A, Armillas-Canseco FM, Mart\u00ednez-Ba\u00f1os D (2011) Antiangiogenesis in myelodysplastic syndrome. Curr Cancer Drug Targets 11(9):1044\u20131052","journal-title":"Curr Cancer Drug Targets"},{"issue":"5","key":"2890_CR10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/ejh.12009","volume":"89","author":"J Paesler","year":"2012","unstructured":"Paesler J, Gehrke I, Poll-Wolbeck SJ, Kreuzer KA (2012) Targeting the vascular endothelial growth factor in hematologic malignancies. Eur J Haematol 89(5):373\u2013384","journal-title":"Eur J Haematol"},{"issue":"2","key":"2890_CR11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1365-2141.2007.06885.x","volume":"140","author":"E Boveri","year":"2008","unstructured":"Boveri E, Passamonti F, Rumi E, Pietra D, Elena C, Arcaini L et al (2008) Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlations. Br J Haematol 140(2):162\u2013168","journal-title":"Br J Haematol"},{"issue":"4","key":"2890_CR12","first-page":"1245","volume":"19","author":"HM Kvasnicka","year":"2004","unstructured":"Kvasnicka HM, Thiele J (2004) Bone marrow angiogenesis: methods of quantification and changes evolving in chronic myeloproliferative disorders. Histol Histopathol 19(4):1245\u20131260","journal-title":"Histol Histopathol"},{"key":"2890_CR13","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1309\/FP0N3LC8MBJUFFA6","volume":"128","author":"U Gianelli","year":"2007","unstructured":"Gianelli U, Vener C, Raviele PR, Savi F, Somalvico F, Calori R et al (2007) VEGF expression correlates with microvessel density in Philadelphia chromosome negative chronic myeloproliferative disorders. Am J Clin Pathol 128:966\u2013973","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"2890_CR14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ajh.10020","volume":"69","author":"C Musolino","year":"2002","unstructured":"Musolino C, Calabro L, Bellomo G, Martello F, Loteta B, Pezzano C et al (2002) Soluble angiogenic factors: implications for chronic myeloproliferative disorders. Am J Hematol 69(3):159\u2013163","journal-title":"Am J Hematol"},{"issue":"8","key":"2890_CR15","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1038\/leu.2013.24","volume":"27","author":"KT Bauerle","year":"2013","unstructured":"Bauerle KT, Schweppe RE, Lund G, Kotnis G, Deep G, Agarwal R et al (2013) Nuclear factor \u03baB-dependent regulation of angiogenesis, and metastasis in an in vivo model of thyroid cancer is associated with secreted interleukin-8. Leukemia 27(8):1697\u20131706","journal-title":"Leukemia"},{"key":"2890_CR16","volume-title":"WHO classification of tumors of haematopoietic and lymphoid tissues","author":"S Swerdlow","year":"2008","unstructured":"Swerdlow S, Campo E, Harris N, Jaffe E, Pileri S, Stein H et al (2008) WHO classification of tumors of haematopoietic and lymphoid tissues. IARC press, Lyon"},{"issue":"6","key":"2890_CR17","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1600-0609.2004.00235.x","volume":"72","author":"K Panteli","year":"2004","unstructured":"Panteli K, Zagorianakou N, Bai M, Katsaraki A, Agnantis NJ, Bourantas K (2004) Angiogenesis in chronic myeloproliferative diseases detected by CD34 expression. Eur J Haematol 72(6):410\u2013415","journal-title":"Eur J Haematol"},{"issue":"6","key":"2890_CR18","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1182\/blood-2006-01-013540","volume":"108","author":"E Lippert","year":"2006","unstructured":"Lippert E, Boissinot M, Kralovics R, Girodon F, Dobo I, Praloran V et al (2006) The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera. Blood 108(6):1865\u20131867","journal-title":"Blood"},{"issue":"6","key":"2890_CR19","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jmoldx.2013.07.006","volume":"15","author":"LV Furtado","year":"2013","unstructured":"Furtado LV, Weigelin HC, Elenitoba-Johnson KS, Betz BL (2013) Detection of MPL mutations by a novel allele-specific PCR-based strategy. J Mol Diagn 15(6):810\u2013818","journal-title":"J Mol Diagn"},{"issue":"12","key":"2890_CR20","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/modpathol.3800224","volume":"17","author":"M Ponzoni","year":"2004","unstructured":"Ponzoni M, Savage DG, Ferreri AJ, Pruneri G, Viale G, Servida P et al (2004) Chronic idiopathic myelofibrosis: independent prognostic importance of bone marrow microvascular density evaluated by CD105 (endoglin) immunostaining. Mod Pathol 17(12):1513\u20131520","journal-title":"Mod Pathol"},{"issue":"2","key":"2890_CR21","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1365-2141.2009.07726.x","volume":"146","author":"M Medinger","year":"2009","unstructured":"Medinger M, Skoda R, Gratwohl A, Theocharides A, Buser A, Heim D et al (2009) Angiogenesis and vascular endothelial growth factor\u2212\/receptor expression in myeloproliferative neoplasms: correlation with clinical parameters and JAK2-V617F mutational status. Br J Haematol 146(2):150\u2013157","journal-title":"Br J Haematol"},{"issue":"3","key":"2890_CR22","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/jcp.2010.083386","volume":"64","author":"L Boiocchi","year":"2011","unstructured":"Boiocchi L, Vener C, Savi F, Bonoldi E, Moro A, Fracchiolla NS et al (2011) Increased expression of vascular endothelial growth factor receptor 1 correlates with VEGF and microvessel density in Philadelphia chromosome-negative myeloproliferative neoplasms. J Clin Pathol 64(3):226\u2013231","journal-title":"J Clin Pathol"},{"issue":"6","key":"2890_CR23","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/10245330701554664","volume":"12","author":"K Panteli","year":"2007","unstructured":"Panteli K, Bai M, Hatzimichael E, Zagorianakou N, Agnantis NJ, Bourantas K (2007 Dec) Serum levels, and bone marrow immunohistochemical expression of, vascular endothelial growth factor in patients with chronic myeloproliferative diseases. Hematology 12(6):481\u2013486","journal-title":"Hematology"},{"key":"2890_CR24","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1182\/blood-2002-06-1811","volume":"100","author":"O Bock","year":"2002","unstructured":"Bock O, Schlue J, Lehmann U, von Wasielewski R, Langer F, Kreipe H (2002) Megakaryocytes from chronic myeloproliferative disorders show enhanced nuclear bFGF expression. Blood 100:2274\u20132275","journal-title":"Blood"},{"key":"2890_CR25","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1200\/JCO.2010.32.9490","volume":"29","author":"A Tefferi","year":"2011","unstructured":"Tefferi A, Vaidya R, Caramazza D, Lasho T, Pardanani A (2011) Circulating interleukin (IL)- 8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study. J Clin Oncol 29:1356\u20131363","journal-title":"J Clin Oncol"},{"issue":"11","key":"2890_CR26","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0145-2126(02)00053-X","volume":"26","author":"P Murphy","year":"2002","unstructured":"Murphy P, Ahmed N, Hassan HT (2002) Increased serum levels of vascular endothelial growth factor correlate with splenomegaly in polycythemia vera. Leuk Res 26(11):1007\u20131010","journal-title":"Leuk Res"},{"key":"2890_CR27","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/sj.leu.2402124","volume":"15","author":"F Di Raimondo","year":"2001","unstructured":"Di Raimondo F, Azzaro MP, Palumbo GA, Bagnato S, Stagno F, Giustolisi GM et al (2001) Elevated vascular endothelial growth factor (VEGF) serum levels in idiopathic myelofibrosis. Leukemia 15:976\u2013980","journal-title":"Leukemia"},{"key":"2890_CR28","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-2141.1997.292671.x","volume":"97","author":"MC Martyr\u00e9","year":"1997","unstructured":"Martyr\u00e9 MC, Le Bousse-Kerdiles MC, Romquin N, Chevillard S, Praloran V, Demory JL et al (1997) Elevated levels of basic fibroblast growth factor in megakaryocytes and platelets from patients with idiopathic myelofibrosis. Br J Haematol 97:441\u2013448","journal-title":"Br J Haematol"},{"issue":"10","key":"2890_CR29","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1182\/blood.V96.10.3374","volume":"96","author":"RA Mesa","year":"2000","unstructured":"Mesa RA, Hanson CA, Rajkumar SV, Schroeder G, Tefferi A (2000) Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia. Blood 96(10):3374\u20133380","journal-title":"Blood"},{"key":"2890_CR30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1309\/4YGKED5LWFW4AVDV","volume":"126","author":"H Ni","year":"2006","unstructured":"Ni H, Barosi G, Hoffman R (2006) Quantitative evaluation of bone marrow angiogenesis in idiopathic myelofibrosis. Am J Clin Pathol 126:241\u2013247","journal-title":"Am J Clin Pathol"},{"key":"2890_CR31","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.humpath.2006.12.011","volume":"38","author":"M Steurer","year":"2007","unstructured":"Steurer M, Zoller H, Augustin F, Fong D, Heiss S, Strasser-Weippl K et al (2007) Increased angiogenesis in chronic idiopathic myelofibrosis: vascular endothelial growth factor as a prominent angiogenic factor. Hum Pathol 38:1057\u20131064","journal-title":"Hum Pathol"},{"issue":"23","key":"2890_CR32","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1200\/JCO.2010.34.5298","volume":"29","author":"T Barbui","year":"2011","unstructured":"Barbui T, Thiele J, Passamonti F, Rumi E, Boveri E, Ruggeri M et al (2011) Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study. J Clin Oncol 29(23):3179\u20133184","journal-title":"J Clin Oncol"},{"issue":"45","key":"2890_CR33","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002003","volume":"94","author":"YQ Deng","year":"2015","unstructured":"Deng YQ, Zhao H, Ma AL, Zhou JY, Xie SB, Zhang XQ et al (2015) Selected cytokines serve as potential biomarkers for predicting liver inflammation and fibrosis in chronic hepatitis B patients with normal to mildly elevated aminotransferases. Medicine (Baltimore) 94(45):e2003. doi: 10.1097\/MD.0000000000002003","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"2890_CR34","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3346\/jkms.2015.30.2.140","volume":"30","author":"JS Lee","year":"2015","unstructured":"Lee JS, Shin JH, Choi BS (2015) Serum levels of IL-8 and ICAM-1 as biomarkers for progressive massive fibrosis in coal workers\u2019 pneumoconiosis. J Korean Med Sci 30(2):140\u2013144","journal-title":"J Korean Med Sci"},{"key":"2890_CR35","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1006\/cyto.2002.1994","volume":"20","author":"S Hermouet","year":"2002","unstructured":"Hermouet S, Godard A, Pineau D et al (2002) Abnormal production of interleukin (IL)-11 and IL-8 in polycythaemia vera. Cytokine 20:178\u2013183","journal-title":"Cytokine"},{"issue":"6","key":"2890_CR36","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/his.12871","volume":"68","author":"HM Kvasnicka","year":"2016","unstructured":"Kvasnicka HM, Beham-Schmid C, Bob R, Dirnhofer S, Hussein K, Kreipe H et al (2016) Problems and pitfalls in grading of bone marrow fibrosis, collagen deposition and osteosclerosis - a consensus-based study. Histopathology 68(6):905\u2013915","journal-title":"Histopathology"},{"issue":"6","key":"2890_CR37","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3324\/haematol.2014.119727","volume":"100","author":"FC Lopes","year":"2015","unstructured":"Lopes FC, Traina F, Almeida CB, Leonardo FC, Franco-Penteado CF, Garrido VT (2015) Key endothelial cell angiogenic mechanisms are stimulated by the circulating milieu in sickle cell disease and attenuated by hydroxyurea. Haematologica 100(6):730\u2013739","journal-title":"Haematologica"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-016-2890-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-016-2890-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-016-2890-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T04:51:56Z","timestamp":1749790316000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-016-2890-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,6]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["2890"],"URL":"https:\/\/doi.org\/10.1007\/s00277-016-2890-9","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,6]]}}}